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Cells can not only sense the type of extracellular matrix (ECM) protein that is present in the micro-
environment, but they can also sense its density. Here, we investigated the effects of ECM protein
density on adipokine secretion and insulin signaling in adipocytes. To this end, 3T3-L1 adipocytes
were cultured on the surface of polyacrylamide gels that were coated with gradient densities of a
collagen type I and ﬁbronectin mixture. We found that high density ECM causes a decrease in insulin
signaling and adiponectin secretion, whereas the secretion of monocyte chemoattractant protein-1
(MCP-1) was increased via the activation of nuclear factor-jB (NF-jB). These results indicate that the
density of the ECM directly regulates the inﬂammatory response and insulin sensitivity of adipo-
cytes.
Structured summary:
MINT-7992217: Irs1 (uniprotkb:P35569) physically interacts (MI:0915) with phosphatidylinositol 3-kinase
85 kDa regulatory subunit alpha (uniprotkb:P26450) by anti bait coimmunoprecipitation (MI:0006)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Insulin acts on adipocytes and skeletal muscle cells to decrease
blood glucose by stimulating glucose uptake. Impaired peripheral
insulin sensitivity plays a central role in the pathogenesis and clin-
ical course of type 2 diabetes and obesity [1]. Therefore, it is of
great importance to clarify the mechanisms involved in the devel-
opment and progression of insulin resistance.
In animal tissues, adhesive cells are usually imbedded in the
extracellular matrix (ECM), which is composed of an interlocking
mesh of proteins including ﬁbronectin, elastin, laminin and various
types of collagen [2]. Recent studies show that, in addition tochemical Societies. Published by E
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ylamide gel electrophoresis;
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. Li).making up the mechanical substratum, the ECM plays an impor-
tant role in the regulation of cell growth, differentiation, migration
and apoptosis [3–5]. Although it is well known that cells can sense
different types of ECM proteins through integrin system [6], how
the quantity of ECM proteins regulates cellular functions is still un-
clear. Recently, Khan et al. found an increased expression of ECM
proteins in adipose tissue from obese mice, and knocking out col-
lagen VI, one of the major ECM proteins in adipose tissue, amelio-
rated insulin resistance in ob/ob obese mice. Interestingly, the
authors also found a low expression of ECM in the adipose tissue
from Caucasian people, who have a lower susceptibility to insulin
resistance [7]. Several earlier in vitro studies found that adipocytic
differentiation was reduced by the upregulation of ECM proteins
induced with transforming growth factor-b1 (TGF-b1) or plasmin-
ogen activator inhibitor-1 (PAI-1) [8,9]. However, whether the den-
sity of ECM directly regulates adipocyte functions or not is still
unknown.
Although 3T3-L1 adipocytes cultured on a rigid surface have
been widely used as an in vitro cellular model of insulin responsive
adipose tissue, one of the challenges is that cells can automatically
secrete many kinds of ECM proteins onto the surface of glass or
plastic tissue culture materials to maintain cell adhesion and
survival [10,11]. Therefore it is difﬁcult to manipulate the density
of ECM proteins with traditional tissue culture methods. In ourlsevier B.V. All rights reserved.
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mic tissue rigidity, we found that the insulin responsiveness of adi-
pocytes is augmented in cells seeded on a matrix whose rigidity
matches that of adipose tissue [12]. In this gel system, ECM com-
posed of a mixture of collagen type 1 and ﬁbronectin is covalently
linked to the surface of gel by the crosslinker, N-succinimide acry-
late. One of the advantages is that once the gels are made, cross-
linkers become inactive so that no additional ECM proteins
secreted from the cells bind to the gel or participate in cell adhe-
sion. Thus, through the use of this gel-based cell culture system,
we evaluated the effects of ECM protein density on the insulin
responsiveness and adipokine expression/secretion of 3T3-L1
adipocytes.2. Materials and methods
2.1. Materials
Calf serum (CS), fetal bovine serum (FBS), penicillin/strepto-
mycin and 0.25% trypsin–EDTA were purchased from Life Technol-
ogies (Carlsbad, CA). Rat tail collagen type 1 and ﬁbronectin,
Dulbecco’s modiﬁed Eagle’s medium (DMEM), dexamethasone,
and 3-isobutyl-1-methylxanthine (IBMX) were obtained from
Sigma–Aldrich (St. Louis, MO). Insulin was purchased from Wako
(Osaka, Japan), and troglitazone was from Cayman Chemical (Ann
Arbor, MI). NE-PER nuclear extraction kit, nuclear factor-jB
(NF-jB) (p65) transcriptional ELISA kit, enhanced chemilumines-
cence (ECL) detection and bicinchoninic acid (BCA) protein assay
kits were purchased from Thermo Scientiﬁc (Rockford, IL). Protein
A/G sepharose beads were from GE Healthcare (Piscataway, NJ).
The ELISA kit for mouse monocyte chemoattractant protein-1
(MCP-1) was obtained from R & D Systems, Inc. (Minneapolis,
MN). The total mouse adiponectin ELISA kit was from B-Bridge
International, Inc. (San Jose, CA). All other analytical grade chemi-
cals were from Wako.
2.2. Antibodies
Anti-IRb, anti-IRS-1, anti-phosphotyrosine (PY20) antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-Akt, anti-phosphoAkt (serine 473), anti-p85-PI3K, and GAPDH
antibodies were purchased from Cell Signaling Technology. Anti-
MCP-1 and anti-adiponectin antibodies were purchased from R &
D Systems, Inc. Horseradish peroxidase (HRP)-conjugated anti-
mouse, anti-rat and anti-rabbit antibodies were obtained from
GE Healthcare (Piscataway, NJ).
2.3. Preparation of polyacrylamide gel substrates
Polyacrylamide gels with rigidity of 250 Pa (Pascal, which is a
unit that describes the viscoelastic property of materials) were pre-
pared as reported previously [12,13]. Brieﬂy, acrylamide (3.0%) and
bis-acrylamide (0.2%) were polymerized with ammonium persul-
fate (1%), and N,N,N0,N0-tetramethylethylenediamine (TEMED,
0.2%) under a non-aqueous layer of toluene containing 0.5% acrylic
acid N-hydroxy succinimide ester (Sigma, St. Louis, MS). The
N-succinimidyl acrylate incorporated at the surface of the gel
reacted with the mixture of 0.01 mg/ml, 0.1 mg/ml, 1 mg/ml type
I collagen and ﬁbronectin (5:1) for 30 min at room temperature
to produce a uniform layer of adhesive ligand. After washing with
phosphate-buffered saline (PBS; NaCl, 137 mmol/l; KCI, 2.7 mmol/
l; Na2HPO4, 10 mmol/l; KH2PO4, 2 mmol/l, pH 7.4) to remove traces
of unpolymerized solvent, the gels were ﬁlled with culture
medium and allowed to equilibrate overnight at 37 C before cells
were seeded.2.4. Cell culture
Murine 3T3-L1 ﬁbroblasts were induced to differentiate as de-
scribed previously [12,14]. Brieﬂy, 3T3-L1 ﬁbroblasts were cul-
tured on polyacrylamide gels with DMEM containing 4.5 g/l
glucose, l-glutamine and 10% CS. Two days after conﬂuence was
achieved, the cells were induced to differentiate by changing the
media to DMEM supplemented with 10% FBS, 0.5 mM IBMX,
1 lM dexamethasone, 1.7 lM insulin and 1 lM troglitazone. After
48 h of induction, the medium was changed to DMEM supple-
mented with 10% FBS, and the cells were fed with fresh medium
every other day thereafter. Experiments were conducted seven
days after inducing differentiation, when >90% of cells expressed
the adipocyte phenotype. Cells were serum-starved (0.2% BSA in
DMEM) overnight before each experiment. This was done to de-
crease the inﬂuence of the basal concentrations of growth factors,
thus avoiding a reduction of cellular responsiveness to insulin
treatment, and to reduce the background signal in the ELISA assay
of secreted MCP-1 and adiponectin.
2.5. Immunoprecipitation
Cells were lysed in RIPA buffer (50 mM Tris, 150 mM NaCl,
1 mM EDTA, 0.5% sodium deoxycholate (wt/vol), 1% Nonidet P-40
(vol/vol), 0.1% SDS (wt/vol), 1 lM aprotinin, 10 lM leupeptin,
0.1 lM phenylmethylsulfonyl ﬂuoride (PMSF), 20 mM sodium
ﬂuoride (NaF), 20 mM beta-glycerolphosphate and 1 mM sodium
orthovanadate, pH 7.4). The lysates were centrifuged for 20 min
at 15,000g at 4 C to remove insoluble materials. The superna-
tants were incubated with the indicated antibodies, after which
the immune complexes were precipitated with protein G sephar-
ose. The immunoprecipitates were then subjected to sodium dode-
cyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and
analyzed by western blot.
2.6. Western blot
Western blot analyses were performed as described previously
[15]. Brieﬂy, after treating the cells as described in the ﬁgure leg-
ends, cells were rinsed three times with ice-cold PBS and lysed in
RIPA buffer. Cell lysates were obtained by centrifugation at
15,000g at 4 C for 20 min. Equal amounts of protein were sub-
jected to sodium dodecyl SDS–PAGE. Proteins were transferred to
an Immobilon-P membrane (Millipore, Bedford, MA). Immunoblot-
ting was performed with an ECL PLUS system. Densitometric anal-
ysis was performed using Scion Image (Scion Corporation,
Frederick, MD).
2.7. Enzyme-linked immunosorbent assay (ELISA) of adiponectin and
MCP-1
The conditioned media obtained after serum-free incubation
were analyzed using the adiponectin (24 h) and MCP-1 (48 h) ELI-
SA Kit according to the manual’s instructions. Data were analyzed
after normalizing with a BCA protein assay.
2.8. Chemiluminescent ELISA-based NF-jB transcription assay
For the NF-jB activation analysis, we used a chemiluminescent
ELISA-based assay (Thermo Scientiﬁc) in which the promoter of the
p65 binding DNA duplex was immobilized on the bottom of 96
well plates. NF-jB (50 ll) binding buffer containing 20 lg/ml Poly
(dI–dC) and 0.8 lM mutant NF-jB competitor DNA duplex or wild
type NF-jB competitor DNA duplex (as a background data) was
added to each well. Then the nuclear cell lysates (5 ll) extracted
with NE-PER nuclear extraction kit were added and incubated for
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chemiluminescent detection of the binding (active) components
of p65 with a Thermo microplate reader. Data were analyzed after
normalizing with a BCA protein assay.
2.9. Statistical analysis
Each experiment was conducted in triplicate (representative re-
sults are shown) and data are expressed as mean ± S.E. P values
were calculated using an unpaired Student’s t-test, and P values
<0.05 were considered signiﬁcant.
3. Results
3.1. High ECM protein density results in decreased insulin
responsiveness in 3T3-L1 adipocytes
One of the primary functions of adipocytes is the uptake of glu-
cose in response to insulin for the purpose of energy storage. Our
previous work showed that 3T3-L1 adipocytes display a similar
phenotype to primary adipocytes when grown on a 250 Pa matrix
(corresponding to the rigidity of adipose tissue): the high insulin
sensitivity and high expression of insulin-responsive glucose trans-
porter type 4 (GLUT4) corresponded with the disappearance ofFig. 1. The high density of ECM proteins decreased insulin responsiveness in 3T3-L1 a
mixture of ECM (collagen type I and ﬁbronectin (5:1) from 0.01 mg/ml, 0.1 mg/ml and 1
5 min. Whole cell lysates were immunoprecipitated with anti-IR (A) or anti-IRS-1 (B) ant
phosphotyrosine antibodies (PY20). After stripping, the membranes were re-immunob
stimulated with 100 nM insulin for 15 min and whole cell lysates were applied to dete
threonine phosphorylation (at position 308, pThr-Akt) and total expression of Akt (Akt).
amount of activated proteins was normalized by the total amount of IR (A), IRS-1 (B) or A
cells on 0.01 mg/ml ECM proteins.insulin-irresponsive GLUT1 expression [12]. In this study, we ap-
plied the same methods by seeding cells on 250 Pa gels. The den-
sity gradient of ECM proteins was generated by incubating the
gels with different concentrations of ECM protein (collagen type
I:ﬁbronectin = 5:1, w/v) solutions from 0.01 mg/ml, 0.1 mg/ml to
1 mg/ml. These are the ideal gradient concentrations for cell adhe-
sion as well as cell responsiveness, according to our pilot experi-
ment (data not shown). Cells were then seeded, and after 2 days,
they were differentiated directly on the gels. At day 6 after the
induction of adipocytic differentiation, the cells were serum-
starved overnight and at day 7, the cells were stimulated with
insulin (100 nM) for 5 min (for detection of the b subunit of insulin
receptor (IRb), insulin receptor substrate-1 (IRS-1) tyrosine phos-
phorylation and p85 subunit of phosphatidylinositol-3-kinase
(p85-PI3K) recruitment) or 15 min (for the detection of Akt phos-
phorylation). The activation of these proteins was analyzed by
western blot followed by a densitometric assay. As shown in
Fig. 1, the insulin-stimulated IRb tyrosine phosphorylation was
downregulated up to 22% with increasing ECM protein density
(Fig. 1A). Moreover, the levels of IRS-1 tyrosine phosphorylation,
p85 subunit of PI3K recruitment and Akt phosphorylation were
also signiﬁcantly attenuated in cells grown on a high density ma-
trix (Fig. 1B and C). Semi-quantitative data tell us that the dense
matrix proteins not only inhibit IR tyrosine phosphorylation, butdipocytes. 3T3-L1 adipocytes cultured on gels with gradient concentrations of the
mg/ml) were serum-starved overnight and then stimulated with 100 nM insulin for
ibodies. Immunoprecipitants were subjected to SDS–PAGE and immunoblotted with
lotted with anti-IRb (A) or anti-IRS-1, anti-p85-PI3K (B) antibodies. (C) cells were
rmine Akt serine phosphorylation (at position 473 in the Akt molecule, pSer-Akt),
Experiments were conducted in triplicate and representative data were shown. The
kt (C). Data are mean ± S.E. and are expressed as fold increase compared to control
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tion (up to 36%) and diminished p85-PI3K recruitment (up to
38%), resulting in the insufﬁcient activation of Akt (up to 40% inhi-
bition). These data show that, due to the impairment of IR/IRS-1
activation, the cells were less insulin responsive on a dense matrix.
The denser the ECM proteins, the less insulin sensitive the cells
were.Fig. 2. High ECM concentration decreased adiponectin expression and secretion. Cell
mixture of ECM were subjected to SDS–PAGE (non-reduced conditions) and immunoblott
were cultured in serum-free media for 24 h and the conditioned media were subjected
protein concentrations determined using the BCA assay).
Fig. 3. A high ECM concentration promotes MCP-1 expression and secretion by activatin
nuclear and cytoplasmic isolation. Ten microliters of nuclear proteins were analyzed by
protein concentrations (A). (B) MCP-1 was analyzed in whole cell lysates from 3T3
representative data are shown. The amount of MCP-1 was normalized by the total expres
control cells on 0.01 mg/ml ECM proteins. (C) Cells were cultured in serum-free media fo
were normalized to the total protein).3.2. High ECM concentration decreases adiponectin expression and
secretion
Rather than being a simple depot for triglycerides, adipose tis-
sue acts as an active secretory organ [16]. A number of cytokines
secreted from adipocytes, called adipokines, regulate whole body
energy homeostasis, including that of adipocytes themselveslysates of 3T3-L1 adipocytes cultured on gels with gradient concentrations of the
ed with anti-adiponectin antibodies. Representative data are presented (A). (B) Cells
to ELISA to determine total adiponectin secretion (data were normalized to total
g nuclear factor-jB (NF-jB). 3T3-L1 adipocytes cultured on gels were collected for
a p65 (NF-jB) transcriptional activity assay and data were normalized with total
-L1 adipocytes by western blot. Experiments were conducted in triplicate and
sion of GAPDH. Data are mean ± S.E. and are expressed as fold increase compared to
r 48 h and MCP-1 secretion in the conditioned media was determined by ELISA (data
Q. Li et al. / FEBS Letters 584 (2010) 4145–4150 4149[17]. Thus, to clarify the role of ECM density on adipokine produc-
tion, we determined the expression/secretion of adiponectin and
monocyte chemoattractant protein-1 (MCP-1), two important but
functionally opposite adipokines with regard to insulin sensitivity.
Adiponectin, an important insulin-sensitizing and anti-inﬂam-
matory adipokine, was identiﬁed as the most abundant adipokine
transcript in adipose tissue [18–21]. Surprisingly, adiponectin was
found to be decreased in obese subjects [22]. This downregulation
has not yet been fully elucidated. The enhanced expression of
ECM in adipose tissue from obese individuals motivated us to
hypothesize that the density of ECM proteins might regulate adipo-
nectin expression in adipocytes. Thus, we determined the expres-
sion of adiponectin in adipocytes by western blot under non-
reducing conditions [23]. As shown in the representative western
blot presented in Fig. 2A, adiponectin was successfully separated
by non-reducing 7% SDS–PAGE. Interestingly, the expression of high
molecular weight (HMW) and medium molecular weight (MMW)
forms andmonomeric adiponectin was reduced in cells grownwith
an increased density of ECM proteins (Fig. 2A). Next, we determined
the secretion of adiponectin by ELISA. After 24 hours of serum-free
incubation, the total adiponectin concentration in the medium was
determined. Consistent with the western blot data, a high density
matrix caused a drop in adiponectin secretion (Fig. 2B).
3.3. High ECM concentration promotes MCP-1 expression and
secretion by activating NF-jB
MCP-1 can be produced by adipocytes and is a potent chemoat-
tractant for monocytes, inducing the pro-inﬂammatory reaction of
adipose tissue [24]. In this study, we determined that increased
ECM density regulates MCP-1 production. Since NF-jB is required
for the induction of MCP-1 transcription [25], we ﬁrst detected the
promoter binding activity of the p65 subunit of NF-jB in the nu-
cleus by ELISA. The result demonstrated that high a density of
ECM proteins improved p65 transcriptional activity (Fig. 3A). NF-
jB activation, therefore, caused the upregulation of MCP-1 expres-
sion (Fig. 3B). Next, we examined the secretion of MCP-1 by ELISA.
After 48 hours of serum-free incubation, the concentration of MCP-
1 was determined in the conditioned media. The results are shown
in Fig. 3C. Consistent with the western blot data, our ELISA data
show that high density matrix proteins induced MCP-1 secretion.4. Discussion
ECM proteins, which are components of tissues, play an impor-
tant role in cell function. The types and ratios of ECM proteins are
regulated by the cell through tightly controlled secretion and deg-
radation by proteases, such as collagenases and metalloproteinases
[26]. The dysregulation of ECM production decreases cell viability
and disturbs tissue remodeling (lack of ECM) and causes ﬁbrotic
diseases (overexpression of ECM). Adipose tissue from obese indi-
viduals with condensed ECM proteins exhibits a low-grade chronic
inﬂammation and a diminished response to insulin stimulation.
This led us to investigate whether the ECM directly affects normal
adipocyte functions [7,27]. The results of this study veriﬁed the
hypothesis that an enhanced density of ECM proteins causes re-
duced insulin sensitivity and adiponectin secretion and incurs a
pro-inﬂammatory status through MCP-1 secretion. Therefore, the
enhanced secretion of ECM proteins in adipose tissue would at
least partially be responsible for insulin resistance and inﬂamma-
tion in vivo. Consistently, recent data from the hypoxia-inducible
factor 1a (HIF1a) transgenic mice revealed that increased ECM
accumulation by overexpression of HIF1a leads to adipose tissue
dysfunction [28]. It is noteworthy that skeletal muscle, another
major insulin-responsive tissue, has also been found to have in-creased collagen content in insulin-resistant subjects, suggesting
a similar pathophysiological role of ECM proteins in the develop-
ment of insulin resistance [29]. Currently, it is still unclear how
the density of ECM proteins modulates insulin sensitivity. How-
ever, there are several potential pathways: First, enhanced ECM
network density might hamper the insulin molecules from inﬁl-
trating to the surface of cells for binding to IR, resulting in insufﬁ-
cient IR activation. Second, the altered release of adipokines such
as adiponectin and MCP-1 might inﬂuence adipocyte function via
the autocrine pathway [30,31]. Third, increased ECM proteins
could affect the assembly of focal adhesions and integrin-cytoskel-
eton interactions and interrupt the activity of related kinases such
as focal adhesion kinase (FAK), rho-kinases or extracellular signal-
regulated kinase (ERK), leading to a direct or indirect modiﬁcation
of insulin signaling molecules such as IRS-1 [32–35]. Further
experiments need to be conducted to clarify the binding efﬁciency
of insulin to IR and the modiﬁcation of IRS-1 molecules.
The physiological actions of adiponectin have been shown to
have insulin-sensitizing, anti-hyperglycemic and anti-inﬂamma-
tory properties as well as anti-atherosclerotic vascular effects
[21,36–38]. Moreover, consistent with our current discovery, vari-
ous insulin resistance-inducing hormones, including b-adrenergic
agonists, IL-6 and glucocorticoids, decrease its expression [39,40].
Insulin-sensitizing thiazolidinediones and glucagon-like peptide-1
receptor (GLP-1R) agonist, on the other hand, profoundly stimulate
adiponectin synthesis, suggesting a role for adiponectin in insulin
sensitivity [41,42]. The next question is: how does ECM density reg-
ulate adiponectin secretion? Since adiponectin is an ECM (gelatin
and collagen) binding protein [43], we suggest it is possible that
an increased ECM density might improve its binding efﬁciency to
conﬁne the massive amount of adiponectin in the ECM to the cell
surface, preventing the facilitation of adiponectin secretion as well
as its release into the medium in vitro (or blood stream in vivo).
MCP-1 secretion is markedly enhanced in adipocytes and adi-
pose tissue of obese subjects, contributing to the inﬂammatory
milieu in obesity [44]. MCP-1 could also decrease insulin-stimu-
lated glucose uptake in adipocytes, indicating the involvement of
MCP-1 in insulin resistance [45]. Therefore, in combination with
the decrease of adiponectin, the over-secretion of MCP-1 could
not only mediate an ECM-induced pro-inﬂammatory reaction,
but it could also aggravate ECM-induced insulin resistance.
Finally, it is worth noting that, although the in vitro results de-
scribed in this study are consistent with the previous in vivo stud-
ies, the adipocyte ECM has a much more complex composition
[46]. Here, however, we used only collagen I and ﬁbronectin as
ECM proteins. To some extent, this may unavoidably limit the
in vivo relevance of such results. Therefore, further investigation
is needed to evaluate the effect of the type of ECM proteins on adi-
pocyte function.5. Conclusion
In summary, this study demonstrates that a high density of ECM
proteins directly prevents insulin responsiveness and promotes a
pro-inﬂammatory reaction by decreasing adiponectin secretion
and promoting MCP-1 secretion through activation of the NF-jB
pathway in adipocytes.Acknowledgements
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